PL352282A1 - Derivatives of thiazoles and pharmaceutical compositions containing these derivatives - Google Patents

Derivatives of thiazoles and pharmaceutical compositions containing these derivatives

Info

Publication number: PL352282A1
Authority: PL; Poland
Prior art keywords: derivatives; thiazoles; pharmaceutical compositions; compositions containing; pharmaceutical
Prior art date: 1999-05-21

Application number

PL00352282A

Inventor

Paul Andrew Brough

Sharon Crawford Cheetham

Frank Kerrigan

John Paul Watts

Original Assignee

Knoll Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-21

Filing date

2000-05-11

Publication date

2003-08-11

2000-05-11 Application filed by Knoll Gmbh filed Critical Knoll Gmbh

2003-08-11 Publication of PL352282A1 publication Critical patent/PL352282A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Hematology (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Addiction (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Anesthesiology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)

PL00352282A 1999-05-21 2000-05-11 Derivatives of thiazoles and pharmaceutical compositions containing these derivatives PL352282A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9911863.0A GB9911863D0 (en)	1999-05-21	1999-05-21	Therapeutic agents
PCT/EP2000/004279 WO2000071549A1 (en)	1999-05-21	2000-05-11	Thiazoloderivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number	Publication Date
PL352282A1 true PL352282A1 (en)	2003-08-11

Family

ID=10853913

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL00352282A PL352282A1 (en)	1999-05-21	2000-05-11	Derivatives of thiazoles and pharmaceutical compositions containing these derivatives

Country Status (19)

Country	Link
EP (1)	EP1178993A1 (en)
JP (1)	JP2003500410A (en)
KR (1)	KR20020033626A (en)
CN (1)	CN1361783A (en)
AU (1)	AU5065700A (en)
BG (1)	BG106227A (en)
BR (1)	BR0010827A (en)
CA (1)	CA2374926A1 (en)
CZ (1)	CZ20014171A3 (en)
GB (1)	GB9911863D0 (en)
HU (1)	HUP0201376A2 (en)
IL (1)	IL146540A0 (en)
MX (1)	MXPA01011895A (en)
NO (1)	NO20015667L (en)
PL (1)	PL352282A1 (en)
SK (1)	SK16852001A3 (en)
TR (1)	TR200200164T2 (en)
WO (1)	WO2000071549A1 (en)
ZA (1)	ZA200110022B (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0005789D0 (en) *	2000-03-11	2000-05-03	Knoll Ag	Therapeutic agents
GB0023610D0 (en) *	2000-09-27	2000-11-08	Knoll Ag	Therapeutic agents
UA76130C2 (en) *	2000-11-20	2006-07-17	Merck Patent Gmbh	Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome
CA2457976A1 (en)	2001-08-22	2003-03-06	Aventis Pharma Deutschland Gmbh	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
US7399777B2 (en)	2001-08-31	2008-07-15	Sanofi-Aventis Deutschland Gmbh	Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
US6884812B2 (en)	2001-08-31	2005-04-26	Aventis Pharma Deutschland Gmbh	Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
ES2278077T3 (en)	2001-08-31	2007-08-01	Sanofi-Aventis Deutschland Gmbh	DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURE FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATORS.
US7078404B2 (en)	2002-04-11	2006-07-18	Sanofi-Aventis Deutschland Gmbh	Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
US7223796B2 (en)	2002-04-11	2007-05-29	Sanofi-Aventis Deutschland Gmbh	Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
US7049341B2 (en)	2002-06-07	2006-05-23	Aventis Pharma Deutschland Gmbh	N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
US7262220B2 (en)	2002-07-11	2007-08-28	Sanofi-Aventis Deutschland Gmbh	Urea- and urethane-substituted acylureas, process for their preparation and their use
DE10231370B4 (en)	2002-07-11	2006-04-06	Sanofi-Aventis Deutschland Gmbh	Thiophene glycoside derivatives, medicaments containing these compounds and methods of making these medicaments
NZ537603A (en)	2002-07-12	2006-09-29	Sanofi Aventis Deutschland	Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
US20040157922A1 (en)	2002-10-04	2004-08-12	Aventis Pharma Deutschland Gmbh	Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments
US7208504B2 (en)	2002-10-12	2007-04-24	Sanofi-Aventis Deutschland Gmbh	Bicyclic inhibitors of hormone sensitive lipase
DE10258007B4 (en)	2002-12-12	2006-02-09	Sanofi-Aventis Deutschland Gmbh	Aromatic fluoroglycoside derivatives, medicaments containing these compounds and methods for the preparation of these medicaments
US20040242583A1 (en)	2003-01-20	2004-12-02	Aventis Pharma Deutschland Gmbh	Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
US7179941B2 (en)	2003-01-23	2007-02-20	Sanofi-Aventis Deutschland Gmbh	Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10306250A1 (en)	2003-02-14	2004-09-09	Aventis Pharma Deutschland Gmbh	Substituted N-aryl heterocycles, processes for their preparation and their use as pharmaceuticals
US7196114B2 (en)	2003-02-17	2007-03-27	Sanofi-Aventis Deutschland Gmbh	Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
DE10308352A1 (en)	2003-02-27	2004-09-09	Aventis Pharma Deutschland Gmbh	Branched side chain arylcycloalkyl derivatives, process for their preparation and their use as medicaments
US7148246B2 (en)	2003-02-27	2006-12-12	Sanofi-Aventis Deutschland Gmbh	Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308353A1 (en)	2003-02-27	2004-12-02	Aventis Pharma Deutschland Gmbh	Diarylcycloalkyl derivatives, processes for their preparation and their use as medicines
DE10308351A1 (en)	2003-02-27	2004-11-25	Aventis Pharma Deutschland Gmbh	1,3-substituted cycloalkyl derivatives having acidic, usually heterocyclic groups, processes for their preparation and their use as medicaments
DE10308355A1 (en)	2003-02-27	2004-12-23	Aventis Pharma Deutschland Gmbh	Aryl-cycloalkyl-substituted alkanoic acid derivatives, process for their preparation and their use as medicaments
US7501440B2 (en)	2003-03-07	2009-03-10	Sanofi-Aventis Deutschland Gmbh	Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
DE10314610A1 (en)	2003-04-01	2004-11-04	Aventis Pharma Deutschland Gmbh	New diphenylazetidinone with improved physiological properties, process for its preparation, medicaments containing these compounds and its use
US7008957B2 (en)	2003-07-25	2006-03-07	Sanofi-Aventis Deutschland Gmbh	Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
US7094800B2 (en)	2003-07-25	2006-08-22	Sanofi-Aventis Deutschland Gmbh	Cyanopyrrolidides, process for their preparation and their use as medicaments
US7094794B2 (en)	2003-07-28	2006-08-22	Sanofi-Aventis Deutschland Gmbh	Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
DE10335092B3 (en)	2003-08-01	2005-02-03	Aventis Pharma Deutschland Gmbh	Substituted benzoylureido-o-benzoylamides, process for their preparation and their use
US7241787B2 (en)	2004-01-25	2007-07-10	Sanofi-Aventis Deutschland Gmbh	Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
US7402674B2 (en)	2004-01-31	2008-07-22	Sanofi-Aventis Deutschland Gmbh,	7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
US7470706B2 (en)	2004-01-31	2008-12-30	Sanofi-Aventis Deutschland Gmbh	Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
US7498341B2 (en)	2004-01-31	2009-03-03	Sanofi Aventis Deutschland Gmbh	Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
DE102004005172A1 (en)	2004-02-02	2005-08-18	Aventis Pharma Deutschland Gmbh	Indazole derivatives as inhibitors of the hormone sensitive lipase
EP1586573B1 (en)	2004-04-01	2007-02-07	Sanofi-Aventis Deutschland GmbH	Oxadiazolones, processes for their preparation and their use as pharmaceuticals
DE102005026762A1 (en)	2005-06-09	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
JP5424480B2 (en)	2006-03-13	2014-02-26	杏林製薬株式会社	Aminoquinolones as GSK-3 inhibitors
DE102006028862A1 (en)	2006-06-23	2007-12-27	Merck Patent Gmbh	3-amino-imidazo [1,2-a] pyridine
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
DE102007002260A1 (en)	2007-01-16	2008-07-31	Sanofi-Aventis	Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome
DE102007008420A1 (en)	2007-02-21	2008-08-28	Merck Patent Gmbh	benzimidazole derivatives
KR101563018B1 (en)	2007-09-11	2015-10-23	교린 세이야꾸 가부시키 가이샤	Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
US8476261B2 (en)	2007-09-12	2013-07-02	Kyorin Pharmaceutical Co., Ltd.	Spirocyclic aminoquinolones as GSK-3 inhibitors
DE102007048716A1 (en)	2007-10-11	2009-04-23	Merck Patent Gmbh	Imidazo [1,2-a] pyrimidine derivatives
DE102007063671A1 (en)	2007-11-13	2009-06-25	Sanofi-Aventis Deutschland Gmbh	New crystalline diphenylazetidinone hydrates, medicaments containing these compounds and their use
US9398944B2 (en)	2008-02-18	2016-07-26	Covidien Lp	Lock bar spring and clip for implant deployment device
US9833240B2 (en)	2008-02-18	2017-12-05	Covidien Lp	Lock bar spring and clip for implant deployment device
US9393093B2 (en)	2008-02-18	2016-07-19	Covidien Lp	Clip for implant deployment device
US8808314B2 (en)	2008-02-18	2014-08-19	Covidien Lp	Device and method for deploying and attaching an implant to a biological tissue
CA2715740C (en)	2008-02-18	2014-05-27	Polytouch Medical Ltd.	A device and method for deploying and attaching a patch to a biological tissue
US8317808B2 (en)	2008-02-18	2012-11-27	Covidien Lp	Device and method for rolling and inserting a prosthetic patch into a body cavity
US9044235B2 (en)	2008-02-18	2015-06-02	Covidien Lp	Magnetic clip for implant deployment device
US8758373B2 (en)	2008-02-18	2014-06-24	Covidien Lp	Means and method for reversibly connecting a patch to a patch deployment device
US9393002B2 (en)	2008-02-18	2016-07-19	Covidien Lp	Clip for implant deployment device
US9034002B2 (en)	2008-02-18	2015-05-19	Covidien Lp	Lock bar spring and clip for implant deployment device
US9301826B2 (en)	2008-02-18	2016-04-05	Covidien Lp	Lock bar spring and clip for implant deployment device
DE102008017590A1 (en)	2008-04-07	2009-10-08	Merck Patent Gmbh	Glucopyranosidderivate
JP2011528321A (en) *	2008-06-21	2011-11-17	ケンバー，エルエルシー	Nutrigenomics method and composition
WO2010003624A2 (en)	2008-07-09	2010-01-14	Sanofi-Aventis	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
EP2337502B1 (en)	2008-10-20	2014-08-06	Covidien LP	A device for attaching a patch to a biological tissue
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2010104205A1 (en)	2009-03-11	2010-09-16	Kyorin Pharmaceutical Co., Ltd.	7-cycloalkylaminoquinolones as gsk-3 inhibitors
CA2769707A1 (en)	2009-08-17	2011-02-24	Tyco Healthcare Group Lp	Articulating patch deployment device and method of use
AU2010286116B2 (en)	2009-08-17	2014-06-26	Covidien Lp	Means and method for reversibly connecting an implant to a deployment device
KR20120060207A (en)	2009-08-26	2012-06-11	사노피	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
EP2482823A2 (en)	2009-10-02	2012-08-08	Sanofi	Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
EP2766349B1 (en)	2011-03-08	2016-06-01	Sanofi	Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683702B1 (en)	2011-03-08	2014-12-24	Sanofi	New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
WO2012120057A1 (en)	2011-03-08	2012-09-13	Sanofi	Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120056A1 (en)	2011-03-08	2012-09-13	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120058A1 (en)	2011-03-08	2012-09-13	Sanofi	Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (en)	2011-03-08	2015-06-24	Sanofi	Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120051A1 (en)	2011-03-08	2012-09-13	Sanofi	Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN114113064B (en) *	2021-12-27	2023-09-08	郑州大学	Light-responsive oxidase based on benzodithiazole, preparation method thereof and application of light-responsive oxidase in colorimetric detection of glutathione in foods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9513467D0 (en) *	1995-07-01	1995-09-06	Knoll Ag	Therapeutic agents
GB9705428D0 (en) *	1997-03-15	1997-04-30	Knoll Ag	Therapeutic agents

1999
- 1999-05-21 GB GBGB9911863.0A patent/GB9911863D0/en not_active Ceased
2000
- 2000-05-11 AU AU50657/00A patent/AU5065700A/en not_active Abandoned
- 2000-05-11 EP EP00935009A patent/EP1178993A1/en not_active Withdrawn
- 2000-05-11 IL IL14654000A patent/IL146540A0/en unknown
- 2000-05-11 MX MXPA01011895A patent/MXPA01011895A/en unknown
- 2000-05-11 HU HU0201376A patent/HUP0201376A2/en unknown
- 2000-05-11 KR KR1020017014892A patent/KR20020033626A/en not_active Application Discontinuation
- 2000-05-11 BR BR0010827-8A patent/BR0010827A/en not_active IP Right Cessation
- 2000-05-11 SK SK1685-2001A patent/SK16852001A3/en unknown
- 2000-05-11 WO PCT/EP2000/004279 patent/WO2000071549A1/en not_active Application Discontinuation
- 2000-05-11 PL PL00352282A patent/PL352282A1/en not_active Application Discontinuation
- 2000-05-11 CN CN00810653A patent/CN1361783A/en active Pending
- 2000-05-11 JP JP2000619805A patent/JP2003500410A/en not_active Withdrawn
- 2000-05-11 CA CA002374926A patent/CA2374926A1/en not_active Abandoned
- 2000-05-11 TR TR2002/00164T patent/TR200200164T2/en unknown
- 2000-05-11 CZ CZ20014171A patent/CZ20014171A3/en unknown
2001
- 2001-11-20 NO NO20015667A patent/NO20015667L/en not_active Application Discontinuation
- 2001-12-05 ZA ZA200110022A patent/ZA200110022B/en unknown
- 2001-12-17 BG BG106227A patent/BG106227A/en unknown

Also Published As

Publication number	Publication date
SK16852001A3 (en)	2002-05-09
AU5065700A (en)	2000-12-12
BR0010827A (en)	2002-06-04
MXPA01011895A (en)	2004-03-19
ZA200110022B (en)	2003-05-28
JP2003500410A (en)	2003-01-07
EP1178993A1 (en)	2002-02-13
NO20015667D0 (en)	2001-11-20
WO2000071549A1 (en)	2000-11-30
HUP0201376A2 (en)	2002-08-28
CZ20014171A3 (en)	2002-06-12
CA2374926A1 (en)	2000-11-30
CN1361783A (en)	2002-07-31
BG106227A (en)	2002-08-30
IL146540A0 (en)	2002-07-25
TR200200164T2 (en)	2002-04-22
KR20020033626A (en)	2002-05-07
NO20015667L (en)	2002-01-21
GB9911863D0 (en)	1999-07-21

Publication	Publication Date	Title
PL352282A1 (en)	2003-08-11	Derivatives of thiazoles and pharmaceutical compositions containing these derivatives
IL149757A0 (en)	2002-12-01	Aminothiazole derivatives and pharmaceutical compositions containing the same
IL147939A0 (en)	2002-08-14	Oxazole and thiazole derivatives and pharmaceutical compositions containing the same
IL133613A0 (en)	2001-04-30	Epothilone derivatives and pharmaceutical compositions containing same
IL147217A0 (en)	2002-11-10	New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HUP0200155A2 (en)	2002-06-29	Thioamide derivatives, pharmaceutical compositions containing them and their use
IL141456A0 (en)	2002-03-10	Rhodanine derivatives and pharmaceutical compositions containing the same
IL149473A0 (en)	2002-11-10	Heterocyclic dihydropyrimidine derivatives and pharmaceutical compositions containing the same
HUP0103406A3 (en)	2002-11-28	1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL148517A0 (en)	2002-09-12	Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0301269A3 (en)	2004-03-29	Phthalazinone derivatives and pharmaceutical compositions containing them
IL150077A0 (en)	2002-12-01	Heterocyclic compounds and pharmaceutical compositions containing the same
IL145428A0 (en)	2002-06-30	Alkanoyl-substituted heterocyclic derivatives and pharmaceutical compositions containing the same
HUP0102990A3 (en)	2002-09-30	Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0201334A2 (en)	2002-10-28	Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same
HUP0201872A2 (en)	2002-10-28	Steroid compounds and pharmaceutical compositions of the same
HUP0101381A3 (en)	2002-06-28	Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL147214A0 (en)	2002-08-14	1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL149883A0 (en)	2002-11-10	Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0103203A3 (en)	2002-10-28	Azaadamantane derivatives and pharmaceutical compositions thereof
HUP0201714A2 (en)	2002-10-28	Substituted heterocyclic compounds and pharmaceutical compositions containing them
IL148807A0 (en)	2002-09-12	Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0200747A2 (en)	2002-06-29	Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0200088A3 (en)	2002-12-28	Pyridazin-3-one derivatives and pharmaceutical compositions containing the same
HUP0400023A2 (en)	2004-04-28	Novel heterocyclic derivatives and medicinal use thereof and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2007-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)